6.
Xie S, Lei H, Yang B, Diao L, Liao J, He J
. Dynamic mA mRNA Methylation Reveals the Role of METTL3/14-mA-MNK2-ERK Signaling Axis in Skeletal Muscle Differentiation and Regeneration. Front Cell Dev Biol. 2021; 9:744171.
PMC: 8517268.
DOI: 10.3389/fcell.2021.744171.
View
7.
Lin R, Zhan M, Yang L, Wang H, Shen H, Huang S
. Deoxycholic acid modulates the progression of gallbladder cancer through N-methyladenosine-dependent microRNA maturation. Oncogene. 2020; 39(26):4983-5000.
PMC: 7314665.
DOI: 10.1038/s41388-020-1349-6.
View
8.
Xu M, Chen X, Chen D, Yu B, Li M, He J
. Regulation of skeletal myogenesis by microRNAs. J Cell Physiol. 2019; 235(1):87-104.
DOI: 10.1002/jcp.28986.
View
9.
Han J, Wang J, Yang X, Yu H, Zhou R, Lu H
. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer. 2019; 18(1):110.
PMC: 6588935.
DOI: 10.1186/s12943-019-1036-9.
View
10.
Ma J, Yang F, Zhou C, Liu F, Yuan J, Wang F
. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2016; 65(2):529-543.
DOI: 10.1002/hep.28885.
View
11.
Wang X, Lu Z, Gomez A, Hon G, Yue Y, Han D
. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2013; 505(7481):117-20.
PMC: 3877715.
DOI: 10.1038/nature12730.
View
12.
Ruiz S, Zhao H, Chandakkar P, Papoin J, Choi H, Nomura-Kitabayashi A
. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. J Clin Invest. 2019; 130(2):942-957.
PMC: 6994128.
DOI: 10.1172/JCI127425.
View
13.
Weskamp K, Olwin B, Parker R
. Post-Transcriptional Regulation in Skeletal Muscle Development, Repair, and Disease. Trends Mol Med. 2021; 27(5):469-481.
DOI: 10.1016/j.molmed.2020.12.002.
View
14.
Deng K, Liu Z, Li X, Zhang Z, Fan Y, Huang Q
. Targeted Demethylation of the TGFβ1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway. Cells. 2023; 12(7).
PMC: 10093215.
DOI: 10.3390/cells12071005.
View
15.
Krist B, Podkalicka P, Mucha O, Mendel M, Sepiol A, Rusiecka O
. miR-378a influences vascularization in skeletal muscles. Cardiovasc Res. 2019; 116(7):1386-1397.
DOI: 10.1093/cvr/cvz236.
View
16.
Li Y, Jiang J, Liu W, Wang H, Zhao L, Liu S
. microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle. Proc Natl Acad Sci U S A. 2018; 115(46):E10849-E10858.
PMC: 6243236.
DOI: 10.1073/pnas.1803377115.
View
17.
Park O, Ha H, Lee Y, Boo S, Kwon D, Song H
. Endoribonucleolytic Cleavage of mA-Containing RNAs by RNase P/MRP Complex. Mol Cell. 2019; 74(3):494-507.e8.
DOI: 10.1016/j.molcel.2019.02.034.
View
18.
Zhang Z, Zhou K, Han L, Small A, Xue J, Huang H
. RNA mA reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression. Genes Dis. 2023; 11(1):382-396.
PMC: 10425806.
DOI: 10.1016/j.gendis.2023.01.016.
View
19.
Chen X, Zhou X, Wang X
. mA binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022; 11(1):21.
PMC: 8981655.
DOI: 10.1186/s40164-022-00269-y.
View
20.
Sekar D, Lakshmanan G
. Methylation of N6-adenosine (m6A) modification in miRNAs and its implications in immunity. Epigenomics. 2020; 12(13):1083-1085.
DOI: 10.2217/epi-2020-0131.
View